Factors predisposing to thrombosis after major joint arthroplasty
Author(s) -
Zoe Dailiana,
Nikolaos Stefanou,
Sokratis Varitimids,
Nikolaos Rigopoulos,
Apostolos Dimitroulias,
Theofilos Karachalios,
Κonstantinos Ν. Malizos,
Despoina Kyriakou,
Panagoula Κollia
Publication year - 2020
Publication title -
world journal of orthopedics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.76
H-Index - 43
ISSN - 2218-5836
DOI - 10.5312/wjo.v11.i9.400
Subject(s) - fondaparinux , medicine , thrombosis , arthroplasty , low molecular weight heparin , antithrombin , osteoarthritis , anticoagulant , thrombophilia , heparin , surgery , pathology , alternative medicine , venous thromboembolism
Total joint arthroplasty is one of the most common options for end stage osteoarthritis of major joints. However, we must take into account that thrombosis after hip/knee arthroplasty may be related to mutations in genes encoding for blood coagulation factors and immune reactions to anticoagulants [heparin-induced thrombocytopenia (HIT)/thrombosis]. Identifying and characterizing genetic risk should help to develop diagnostic strategies or modify anticoagulant options in the search for etiological mechanisms that cause thrombophilia following major orthopedic surgery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom